Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Tin-mesoporphyrin in the Treatment of Severe Hyperbilirubinemia in a Very-low-birth-weight Infant

Abstract

Tin-mesoporphyrin (SnMP) is a competitive inhibitor of microsomal heme oxygenase (the rate-limiting enzyme in the heme catabolic pathway). It was administered as a single intramuscular dose at 46 hours of life to a very-low-birth-weight infant with severe hemolytic hyperbilirubinemia who had been awaiting an exchange transfusion. This case documents the effective elimination of the need for an exchange transfusion in a very-low-birth-weight infant and is a confirmation of the experience of others for the use of SnMP in reducing bilirubin production.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

John A. Kellum, Paola Romagnani, … Hans-Joachim Anders

References

  1. Valaes T, Petmezaki S, Henschke C, Drummond GS, Kappas A . Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics 1994;93:1–11.

    CAS  PubMed  Google Scholar 

  2. Kappas A, Drummond GS, Henschke C, Valaes T . Direct comparison of Sn-mesoporphyrin an inhibitor of bilirubin production and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics 1995;95:468–474.

    CAS  PubMed  Google Scholar 

  3. Kappas A, Drummond GS, Munson DP, Marshall JR . Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Pediatrics 2001;108:1374–1377.

    Article  CAS  Google Scholar 

  4. Kappas A, Drummond GS, Valaes T . A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics 2001;108:25–30.

    Article  CAS  Google Scholar 

  5. Galbraith RA, Drummond GS, Kappas A . Suppression of bilirubin production in the Crigler–Najjar type I syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin. Pediatrics 1992;89:175–182.

    CAS  PubMed  Google Scholar 

  6. Rubaltalli FF, Dario C, Zancan L . Congenital nonobstructive, nonhemolytic jaundice: effect of tin-mesoporphyrin. Pediatrics 1994;95:942–944.

    Google Scholar 

  7. Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T . Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 1988;81:485–497.

    CAS  Google Scholar 

  8. Maisels MJ . Neonatal jaundice. In: Avery GB, Fletcher MA, MacDonald M, editors. Neonatology: Pathophysiology and Management of the Newborn. Philadelphia, PA: JB Lippincott; 1994.

    Google Scholar 

  9. Martinez JC, Garcia HO, Otheguy LE, Drummond GS, Kappas A . Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics. 1999;108:25–30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reddy, P., Najundaswamy, S., Mehta, R. et al. Tin-mesoporphyrin in the Treatment of Severe Hyperbilirubinemia in a Very-low-birth-weight Infant. J Perinatol 23, 507–508 (2003). https://doi.org/10.1038/sj.jp.7210943

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7210943

This article is cited by

Search

Quick links